5-(cyclopentylmethyl)-1,3,4-thiadiazol-2-amine, 95.0%, 250mg

3-(Morpholine-4-carbonyl)benzonitrile, 98%, 5g

1-(2,6-Dimethylpyridin-3-yl)ethan-1-one, 97%, 1g

5-Fluoro-2-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 95+%, 100mg

2-Acetamidoethanol>90.0%(GC)500g

N-(2-nitrophenyl)ethane-1,2-diamine, 95.0%, 5g

3-BROMO-1H-INDAZOLE-7-CARBOXYLIC ACID, 98%, 250mg

2-(4-Bromo-1H-imidazol-1-yl)pyridine, 95.0%, 250mg

(R)-2-((4-Aminophenethyl)amino)-1-phenylethanol hydrochloride, 95.0%, 10g

2-Chloro-n-(1,3,5-trimethyl-1h-pyrazol-4-yl)acetamide, 98%, 100mg

2,6-Bis((R)-4-isopropyl-4,5-dihydrooxazol-2-yl)pyridine, 95.0%, 250mg

Fmoc-L-ácido glutámico-(OtBu) monohidrato, 5 g, >=99 %, para bioquímica, envases de vidrio

4-Chloro-2-cyanopyridine, 98.0%, 5g